Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TDS Pharm Co's Enterprise Value is ₩15,326 Mil.
TDS Pharm Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was ₩6,445 Mil. Therefore, TDS Pharm Co's EV-to-EBIT ratio for today is 2.38.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, TDS Pharm Co's Enterprise Value is ₩15,326 Mil.
TDS Pharm Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₩7,169 Mil. Therefore, TDS Pharm Co's EV-to-EBITDA ratio for today is 2.14.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, TDS Pharm Co's Enterprise Value is ₩15,326 Mil.
TDS Pharm Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ₩32,905 Mil. Therefore, TDS Pharm Co's EV-to-Revenue ratio for today is 0.47.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, TDS Pharm Co's Enterprise Value is ₩15,326 Mil.
TDS Pharm Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₩-6,034 Mil. Therefore, TDS Pharm Co's EV-to-FCF ratio for today is -2.54.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
TDS Pharm Co (XKRX:464280) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
TDS Pharm Co's current Enterprise Value is ₩15,326 Mil.
TDS Pharm Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,445 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
TDS Pharm Co's current Enterprise Value is ₩15,326 Mil.
TDS Pharm Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,169 Mil.
TDS Pharm Co's current Enterprise Value is ₩15,326 Mil.
TDS Pharm Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩32,905 Mil.
TDS Pharm Co's current Enterprise Value is ₩15,326 Mil.
TDS Pharm Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,525 Mil.
TDS Pharm Co's current Enterprise Value is ₩15,326 Mil.
TDS Pharm Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,034 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TDS Pharm Co Enterprise Value Related Terms
TDS Pharm Co Enterprise Value Historical Data
* Premium members only.
The historical data trend for TDS Pharm Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:464280 vs LLY, JNJ, ABBV: Enterprise Value Comparison
For the Drug Manufacturers - General subindustry, TDS Pharm Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TDS Pharm Co Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where TDS Pharm Co's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
TDS Pharm Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TDS Pharm Co (XKRX:464280) has a Enterprise Value of ₩15,326 Mil as of Sep. 13, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on TDS Pharm Co and its competitors.
Is TDS Pharm Co's Enterprise Value too high?
TDS Pharm Co's current Enterprise Value is ₩15,326 Mil. Overall, TDS Pharm Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does TDS Pharm Co's Enterprise Value compare to LLY and JNJ?
TDS Pharm Co's Enterprise Value of ₩15,326 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on TDS Pharm Co and its competitors. TDS Pharm Co's current Enterprise Value is ₩15,326 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TDS Pharm Co stock overvalued right now?
TDS Pharm Co (XKRX:464280) has a current Enterprise Value of ₩15,326 Mil. The current Enterprise Value is ₩15,326 Mil. TDS Pharm Co's overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For TDS Pharm Co (XKRX:464280), the current Enterprise Value is ₩15,326 Mil as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.
40GF Score
Get the complete analysis for XKRX:464280
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:464280 has been successfully added to your 
